Search | TVST | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Plasma-derived cell free DNA for the diagnosis of ocular-involving histiocytosis

Jasmine H Francis; Maria Arcila; David H Abramson; Eli Diamond

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1470.

Retina September 2023

Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model

PDF

Flavio Requejo; Javier Opezzo; Alan Vater; Marcelo Asprea; Eduardo Lagomarsino; Claudia Sampor; Adriana Fandiño; Guillermo Chantada; Jasmine H. Francis; David H. Abramson; Paula Schaiquevich
TAGS: intravenous infusion procedures, ophthalmic artery, retinoblastoma, suidae, topotecan, pharmacokinetics, orbit
Invest. Ophthalmol. Vis. Sci.. 2023; 64(12):3. https://doi.org/10.1167/iovs.64.12.3

Anatomy and Pathology/Oncology December 2022

Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma

PDF

Jasmine H. Francis; Christopher A. Barker; A. Rose Brannon; Julia Canestraro; Melissa Robbins; Christina E. Swartzwelder; Sara Levine; Crystal Law; Michael F. Berger; Alexander Shoushtari; David H. Abramson
TAGS: circulating tumor dna, intraocular melanoma, plasma
Invest. Ophthalmol. Vis. Sci.. 2022; 63(13):17. https://doi.org/10.1167/iovs.63.13.17

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Fundus Autofluorescence Patterns Before and After Treatment for Primary Vitreoretinal Lymphoma

Ethan K Sobol; David H Abramson; Jasmine H Francis

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5329.

ARVO Annual Meeting Abstract July 2019

Optical Coherence Tomography (OCT) characteristics of the choroid underlying congenital hypertrophy of the retinal pigment epithelium (CHRPE)

Ethan Sobol; Jasmine H. Francis; Molly Greenberg; Robert Folberg; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3552.

Perspective January 2019

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference

PDF

Justine R. Smith; Jacob Pe'er; Rubens N. Belfort; Fatima Cardoso; Richard D. Carvajal; Carlos Carvalho; Sarah E. Coupland; Laurence Desjardins; Jasmine H. Francis; Brenda L. Gallie; Dan S. Gombos; Hans E. Grossniklaus; Steffen Heegaard; Martine J. Jager; Swathi Kaliki; Bruce R. Ksander; Markus Maeurer; Eduardo Moreno; Jose S. Pulido; Bettina Ryll; Arun D. Singh; Junyang Zhao; António Parreira; David J. Wilson; Joan M. O'Brien
TAGS: carcinogenesis, medical oncology, ophthalmology, tumorigenesis, vision research, intraocular melanoma, neoplasms, cancer, eye cancer
Trans. Vis. Sci. Tech.. 2019; 8(1):9. https://doi.org/10.1167/tvst.8.1.9

ARVO Annual Meeting Abstract July 2018

Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery

Megan Rowlands; Ijah Mondesire-Crump; Ariana Levin; Audrey Mauguen; Jasmine H Francis; Ira Dunkel; Scott E Brodie; Yves Pierre Gobin; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1644.

Anatomy and Pathology/Oncology January 2018

BRAF , NRAS , and GNAQ Mutations in Conjunctival Melanocytic Nevi

PDF

Jasmine H. Francis; Hans E. Grossniklaus; Larissa A. Habib; Brian Marr; David H. Abramson; Klaus J. Busam
TAGS: braf gene, conjunctiva, melanocytic nevus, mutation, nevus of conjunctiva, nevus
Invest. Ophthalmol. Vis. Sci.. 2018; 59(1):117-121. https://doi.org/10.1167/iovs.17-22517

ARVO Annual Meeting Abstract June 2017

Second Primary Malignancies in Retinoblastoma Patients Treated with Intraarterial Chemotherapy: The First Ten Years.

Larissa Habib; Jasmine H Francis; Pierre Gobin; Brian Marr; Ira J. Dunkel; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3337.

ARVO Annual Meeting Abstract June 2017

Choroidal infarction following ophthalmic artery chemotherapy

Kelley Bohm; Pierre Gobin; Jasmine H Francis; Brian Marr; Anahita Dabo-Trubelja; Paul H Dalecki; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3339.

ARVO Annual Meeting Abstract June 2017

A comparison of retinoblastoma vitreous seed clouds (class 3) treated with ophthalmic artery chemosurgery with or without intravitreous chemotherapy

Jasmine H Francis; Saipriya Iyer; Pierre Gobin; Brian Marr; Scott E Brodie; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3340.

ARVO Annual Meeting Abstract September 2016

An International Survey of Classification and Treatment Choices for Group D Retinoblastoma Eyes

Christina Scelfo; Jasmine H Francis; Thomas Lee Jenkins; Brian P Marr; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3676.

ARVO Annual Meeting Abstract September 2016

Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

Ijah Mondesire-Crump; Brian P Marr; Jasmine H Francis; Ira Dunkel; Pierre Gobin; Armida Fabius; Scott E Brodie; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Clinical Characterization of Vitreous Seeds in Retinoblastoma

Jasmine H Francis; Brian P Marr; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3675.

ARVO Annual Meeting Abstract September 2016

Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function

Aliaa H Abdelhakim; Jasmine H Francis; Pierre Gobin; Brian P Marr; David H Abramson; Scott E Brodie

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3680.

ARVO Annual Meeting Abstract September 2016

Neutrophil to Lymphocyte Ratio in Patients with Primary Uveal Melanoma

Saipriya Iyer; Christopher A. Barker; David H Abramson; Brian P Marr; Jasmine H Francis

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5888.

ARVO Annual Meeting Abstract June 2015

The Classification of Vitreous Seeds in Retinoblastoma: Response to Intravitreal Melphalan

Jasmine H Francis; David H Abramson; Marie-Claire Gaillard; Brian P Marr; Maya Beck-Popovic; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1290.

ARVO Annual Meeting Abstract June 2015

Orbital Retinoblastoma: Enucleation vs. Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma

Nicolas Alessandro Yannuzzi; Jasmine H Francis; Brian P Marr; Irina Belinsky; Ira Dunkel; Y. Pierre Gobin; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):85.

ARVO Annual Meeting Abstract April 2014

Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma

Anthony Daniels; Y. Pierre Gobin; Brian Marr; Jasmine H Francis; Scott E Brodie; David H Abramson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3090.

ARVO Annual Meeting Abstract April 2014

Efficacy of second-course ophthalmic artery chemosurgery for retinoblastoma

Jasmine H Francis; Y. P Gobin; Brian Marr; Irwin Tendler; Scott E Brodie; David H Abramson; Ira J Dunkel

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3091.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Plasma-derived cell free DNA for the diagnosis of ocular-involving histiocytosis

Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model

Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma

Fundus Autofluorescence Patterns Before and After Treatment for Primary Vitreoretinal Lymphoma

Optical Coherence Tomography (OCT) characteristics of the choroid underlying congenital hypertrophy of the retinal pigment epithelium (CHRPE)

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference

Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery

BRAF , NRAS , and GNAQ Mutations in Conjunctival Melanocytic Nevi

Second Primary Malignancies in Retinoblastoma Patients Treated with Intraarterial Chemotherapy: The First Ten Years.

Choroidal infarction following ophthalmic artery chemotherapy

A comparison of retinoblastoma vitreous seed clouds (class 3) treated with ophthalmic artery chemosurgery with or without intravitreous chemotherapy

An International Survey of Classification and Treatment Choices for Group D Retinoblastoma Eyes

Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

Clinical Characterization of Vitreous Seeds in Retinoblastoma

Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function

Neutrophil to Lymphocyte Ratio in Patients with Primary Uveal Melanoma

The Classification of Vitreous Seeds in Retinoblastoma: Response to Intravitreal Melphalan

Orbital Retinoblastoma: Enucleation vs. Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma

Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma

Efficacy of second-course ophthalmic artery chemosurgery for retinoblastoma

To View More...

You must be signed into an individual account to use this feature.